Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgene as vaccine for chlamydia.

R C Brunham1, Dj Zhang

  • 1Department of Medical Microbiology, University of Manitoba. Winnipeg, Canada.

American Heart Journal
|October 28, 1999
PubMed
Summary

DNA immunization using the Chlamydia trachomatis major outer membrane protein (MOMP) gene offers protective immunity against chlamydial infection. Mucosal delivery routes proved more effective than intramuscular injections for this novel vaccine approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Birth cohort patterns suggest that infant survival predicts adult mortality rates.

Journal of developmental origins of health and disease·2014
Same author

Etiology of cervicitis and treatment with minocycline.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

In celebration of the 200th anniversary of Edward Jenner's Inquiry into the causes and effects of the variolae vaccinae.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Identification of a novel HLA-A allele, A*29:28, in an East African population.

Tissue antigens·2011
Same author

Evidence that human Chlamydia pneumoniae was zoonotically acquired.

Journal of bacteriology·2009
Same author

Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2008

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Chlamydia trachomatis mouse pneumonitis (MoPn) strain poses a significant challenge for developing effective treatments.
  • The major outer membrane protein (MOMP) is a key target for inducing protective immunity against chlamydial infections.

Purpose of the Study:

  • To evaluate the efficacy of DNA immunization targeting the MOMP gene of C. trachomatis MoPn strain.
  • To assess the potential of DNA vaccination for inducing protective immunity against chlamydial infection in a mouse model.

Main Methods:

  • Balb/c mice were immunized via intramuscular, intranasal, or oral routes using naked DNA or DNA-transfected Salmonella typhimurium.
  • Mice were subsequently challenged with the MoPn strain via the pulmonary route to determine the level of protective immunity.

Main Results:

  • All three routes of DNA immunization successfully elicited protective immunity against chlamydial challenge.
  • Intranasal and oral mucosal delivery methods demonstrated greater efficacy compared to intramuscular delivery.

Conclusions:

  • DNA immunization targeting the MOMP gene of Chlamydia trachomatis is a promising strategy for vaccine development.
  • Mucosal administration of DNA vaccines warrants further investigation for enhanced protection against chlamydial infections.

Related Experiment Videos